Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors

Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide

(2012) Robert S. Wallis et al.   PLoS One

Design, Synthesis, and Evaluation of Thiol-Activated Sources of Sulfur Dioxide (SO2) as Antimycobacterial Agents

(2011) Satish R. Malwal et al.   JOURNAL OF MEDICINAL CHEMISTRY

Current Status and Research Strategies in Tuberculosis Drug Development

(2011) Lynn G. Dover et al.   JOURNAL OF MEDICINAL CHEMISTRY

Design, Synthesis, and Study of a Mycobactin−Artemisinin Conjugate That Has Selective and Potent Activity against Tuberculosis and Malaria

(2011) Marvin J. Miller et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Selective killing of cancer cells by a small molecule targeting the stress response to ROS

(2011) Lakshmi Raj et al.   NATURE

Chemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell Death

(2010) Joseph S. Bair et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities

(2009) Georg T. Wondrak   ANTIOXIDANTS & REDOX SIGNALING

Redox control in actinobacteria

(2008) Chris D. den Hengst et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release

(2008) R. Singh et al.   SCIENCE